Michael Ryskin
Stock Analyst at B of A Securities
(1.39)
# 3,611
Out of 5,146 analysts
40
Total ratings
48%
Success rate
-2.81%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Maintains: Neutral | $135 → $140 | $128.95 | +8.57% | 8 | Feb 13, 2026 | |
| SDGR Schrödinger | Upgrades: Buy | $24 | $11.80 | +103.39% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $97.57 | +1.47% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $53.71 | +30.33% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $657.38 | -27.74% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.26 | +145.40% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $188.05 | +9.55% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $95.27 | -58.01% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $0.79 | +1,103.90% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $6.59 | +264.19% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $24 | $9.06 | +164.90% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.77 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $2.74 | +264.96% | 2 | Nov 10, 2021 |
Zoetis
Feb 13, 2026
Maintains: Neutral
Price Target: $135 → $140
Current: $128.95
Upside: +8.57%
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $11.80
Upside: +103.39%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $97.57
Upside: +1.47%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $53.71
Upside: +30.33%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $657.38
Upside: -27.74%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.26
Upside: +145.40%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $188.05
Upside: +9.55%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $95.27
Upside: -58.01%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $0.79
Upside: +1,103.90%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $6.59
Upside: +264.19%
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $9.06
Upside: +164.90%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.77
Upside: -
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $2.74
Upside: +264.96%